Copyright: ©Author(s) 2026.
Artif Intell Gastrointest Endosc. Sep 8, 2026; 7(2): 118493
Published online Sep 8, 2026. doi: 10.37126/aige.118493
Published online Sep 8, 2026. doi: 10.37126/aige.118493
Figure 1 Comparison of artificial intelligence sensitivity for neoplasia detection across commercial non-inflammatory bowel disease systems and inflammatory bowel disease-specific models.
Illustrative only, methodological heterogeneity limits direct benchmarking. AI: Artificial intelligence; IBD: Inflammatory bowel disease; CADe: Computer-aided detection.
- Citation: Bhandari R, Gartlan J, Oppong P, Chhabra P. Artificial intelligence for inflammatory bowel disease dysplasia detection: Current evidence and future directions. Artif Intell Gastrointest Endosc 2026; 7(2): 118493
- URL: https://www.wjgnet.com/2689-7164/full/v7/i2/118493.htm
- DOI: https://dx.doi.org/10.37126/aige.118493